| 000 | 01449 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515145826.0 | ||
| 264 | 0 | _c20090107 | |
| 008 | 200901s 0 0 eng d | ||
| 022 | _a0949-2321 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWasmuth, J-C | |
| 245 | 0 | 0 |
_aFatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma. _h[electronic resource] |
| 260 |
_bEuropean journal of medical research _cOct 2008 |
||
| 300 |
_a483-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCyclophosphamide _xadverse effects |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xpathology |
| 650 | 0 | 4 |
_aLiver Failure, Acute _xetiology |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aVidarabine _xadverse effects |
| 700 | 1 | _aFischer, H-P | |
| 700 | 1 | _aSauerbruch, T | |
| 700 | 1 | _aDumoulin, F L | |
| 773 | 0 |
_tEuropean journal of medical research _gvol. 13 _gno. 10 _gp. 483-6 |
|
| 999 |
_c18465633 _d18465633 |
||